课题基金 / 基金详情

Investigation on Molecular Link Between the Phosphatidylinositol 3-Kinase Signaling Pathway and the Cell Cycle Machinery

Investigation on Molecular Link Between the Phosphatidylinositol 3-Kinase Signaling Pathway and the Cell Cycle Machinery
磷脂酰肌醇 3-激酶信号通路与细胞周期机制之间的分子联系研究
批准号:
11670035
负责人:
TAKUWA Noriko
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

TAKUWA Noriko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Phosphatidylinositol (PI) 3-kinase is required for G1 to S phase cell cycle progression stimulated by a variety of growth factors, and is implicated as a regulator for activation of several downstream targets, including p70^<S6K>. However, molecular mechanisms by which PI 3-kinase is engaged in the activation of the cell cycle machinery is not fully understood. Here we report that a transient expression of wild type p110α catalytic subunit of PI 3-kinase was capable of inducing cyclin D1 protein in quiescent NIH3T3 (M17) fibroblasts. This effect of p110 was strongly attenuated by either the PI 3-kinase inhibitor LY294002 or rapamycin, but not by an induced expression of a dominant negative (DN-) Ras, Ras(Asn17). The expression of wild type p110 also greatly potentiated epidermal growth factor (EGF)-stimulated cyclin D1 protein expression. Conversely, the expression of a DN-form of either p110 or p85 regulatory subunit of PI 3-kinase strongly inhibited EGF-induced up-regulation of cyclin D1 protein. LY294002 and another PI 3-kinase inhibitor wortmannin completely abrogated EGF-stimulated increases in both mRNA and protein levels of cyclin D1, pRb phosphorylation and S phase entry. However, rapamycin had little inhibitory effect, if any, on either of these events despite potent p70^<S6K> inhibition throughout the G1 phase. These results indicate that PI 3-kinase is both necessary and sufficient for up-regulation of cyclin D1, with the downstream mTOR -p70^<S6K> signaling pathway differentially required depending on cellular conditions.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Noriko TAKUWA et al.: "Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70 sik-independent signaling in growth factor-stimulated NIH3T3 fibroblasts"Molecular and Cellular Biology. Vol.19,No.2. 1346-1358 (1999)
Noriko TAKUWA 等人:“在生长因子刺激的 NIH3T3 成纤维细胞中,磷脂酰肌醇 3 激酶通过 mTOR-p70 sik 独立信号传导介导细胞周期蛋白 D1 表达”分子和细胞生物学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Mitsui, et al.: "The MEKI-ERK-MAP Kinase pathway and the PI 3-kinase-Akt pathway independently mediate anti-apoptotic Signals in HepG2 Qiver cancer cells."Int.J.Cancer. (in press). (2001)
H.Mitsui 等人:“MEKI-ERK-MAP 激酶途径和 PI 3-激酶-Akt 途径独立介导 HepG2 Qiver 癌细胞中的抗凋亡信号。”Int.J.Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Takuwa, H.Okamoto, N.Takuwa, K.Gonda, N.Sugimoto and S.Sakurada.: "Subtype-Specific, Differential Activities of the EDG Family Receptors for Sphingosine-1-Phosphate, a Novel Lysophospholipid Mediateor."Mol.Cell.Endocrinol.. (in press). (2001)
Y.Takuwa、H.Okamoto、N.Takuwa、K.Gonda、N.Sugimoto 和 S.Sakurada.:“EDG 家族受体对 1-磷酸鞘氨醇(一种新型溶血磷脂介质)的亚型特异性、差异活性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Regulation of tumor angiogenesis and metastasis, and postischemic angiogenesis by sphingosine-1-phosphate signaling system
  • 批准号:
    23590344
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2011
  • 负责人:
    TAKUWA Noriko
  • 依托单位:
Pathophysiological roles of the sphingosine-1-phosphate signaling system in vivo
  • 批准号:
    20590288
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2008
  • 负责人:
    TAKUWA Noriko
  • 依托单位:
Molecular mechanisums for S1P_2 G protein coupled receptor-mediated inhibition of tumor progression
  • 批准号:
    18590259
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.55万
  • 财政年份:
    2006
  • 负责人:
    TAKUWA Noriko
  • 依托单位:
Physiological and pathophysiological roles of the S1P signaling system : an in vivo study
国内基金
海外基金
基于p53/p21/Cyclin D/E介导的细胞周期异常及Bcl-2/Bax/Caspase-3/PARP介导的凋亡途径研究积雪草苷NO凝胶激活糖化皮肤成纤维细胞再生促进DM皮肤创伤愈合的机制
  • 批准号:
    82160770
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35万元
  • 批准年份:
    2021
  • 负责人:
    聂绪强
  • 依托单位:
稀土,氟尿嘧啶在其配合物中协同抗胃癌作用及对cyclin D/Rb-E2F通路的协同干预作用
  • 批准号:
    81060271
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2010
  • 负责人:
    胡智兴
  • 依托单位: